Can the new American Joint Committee on Cancer staging system predict survival in rectal cancer patients treated with curative surgery following preoperative chemoradiotherapy?

Cancer ◽  
2012 ◽  
Vol 118 (20) ◽  
pp. 4961-4968 ◽  
Author(s):  
Sang Hui Moon ◽  
Dae Yong Kim ◽  
Ji Won Park ◽  
Jae Hwan Oh ◽  
Hee Jin Chang ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Cancer Patients ◽  
Staging System ◽  
Cancer Staging ◽  
Preoperative Chemoradiotherapy ◽  
Curative Surgery ◽  
American Joint Committee

scholarly journals Is the N1c category of the new american joint committee on cancer staging system applicable to patients with rectal cancer who receive preoperative chemoradiotherapy?

Cancer ◽  
2011 ◽  
Vol 117 (17) ◽  
pp. 3917-3924 ◽  
Author(s):  
Joon Seon Song ◽  
Hee Jin Chang ◽  
Dae Yong Kim ◽  
Sun Young Kim ◽  
Ji Yeon Baek ◽  
...  
Keyword(s):  
Rectal Cancer ◽  
Staging System ◽  
Cancer Staging ◽  
Preoperative Chemoradiotherapy ◽  
American Joint Committee

Prognostic impact of the 8th edition of American Joint Committee on Cancer (AJCC) cancer staging system on clinically negative lymph nodes (cN0) breast cancer patients

2020 ◽  
Vol 26 (7) ◽  
pp. 1265-1269 ◽  
Author(s):  
Augusto Lombardi ◽  
Valeria Vitale ◽  
Giuseppe Nigri ◽  
Carlotta Olivieri ◽  
Maria Rosaria Mastrangeli ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Lymph Nodes ◽  
Cancer Patients ◽  
Staging System ◽  
Cancer Staging ◽  
Prognostic Impact ◽  
Breast Cancer Patients ◽  
American Joint Committee ◽  
Negative Lymph Nodes ◽  
8Th Edition

Final Version of the American Joint Committee on Cancer Staging System for Cutaneous Melanoma

2001 ◽  
Vol 19 (16) ◽  
pp. 3635-3648 ◽  
Author(s):  
Charles M. Balch ◽  
Antonio C. Buzaid ◽  
Seng-Jaw Soong ◽  
Michael B. Atkins ◽  
Natale Cascinelli ◽  
...  
Keyword(s):  
Cutaneous Melanoma ◽  
Elevated Serum ◽  
Primary Melanoma ◽  
Staging System ◽  
Distant Metastases ◽  
Lactic Dehydrogenase ◽  
Cancer Staging ◽  
Sixth Edition ◽  
Stage Grouping ◽  
American Joint Committee

PURPOSE: To revise the staging system for cutaneous melanoma under the auspices of the American Joint Committee on Cancer (AJCC). MATERIALS AND METHODS: The prognostic factors analysis described in the companion publication (this issue), as well as evidence from the published literature, was used to assemble the tumor-node-metastasis criteria and stage grouping for the melanoma staging system. RESULTS: Major changes include (1) melanoma thickness and ulceration but not level of invasion to be used in the T category (except for T1 melanomas); (2) the number of metastatic lymph nodes rather than their gross dimensions and the delineation of clinically occult (ie, microscopic) versus clinically apparent (ie, macroscopic) nodal metastases to be used in the N category; (3) the site of distant metastases and the presence of elevated serum lactic dehydrogenase to be used in the M category; (4) an upstaging of all patients with stage I, II, and III disease when a primary melanoma is ulcerated; (5) a merging of satellite metastases around a primary melanoma and in-transit metastases into a single staging entity that is grouped into stage III disease; and (6) a new convention for defining clinical and pathologic staging so as to take into account the staging information gained from intraoperative lymphatic mapping and sentinel node biopsy. CONCLUSION: This revision will become official with publication of the sixth edition of the AJCC Cancer Staging Manual in the year 2002.

Sign in / Sign up

Export Citation Format

Share Document